SEC Form 4 · accession 0001209191-17-058948

Biohaven Pharmaceutical Holding Co Ltd. · BHVN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Vlad Coric

Officer — Chief Executive Officer · Director

Period of report

Oct 31, 2017

Accepted (ET)

Nov 2, 2017 · 5:54 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001689813

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Shares^F2,F3	Oct 31, 2017	S	25,828	$29.04	D	624,172	I	See Footnote
Common Shares^F4,F3	Oct 31, 2017	S	23,122	$29.96	D	601,050	I	See Footnote
Common Shares^F5,F3	Oct 31, 2017	S	1,050	$30.51	D	600,000	I	See Footnote
Common Shares^F2,F6	Oct 31, 2017	S	25,827	$29.04	D	624,173	I	See Footnote
Common Shares^F4,F6	Oct 31, 2017	S	23,123	$29.96	D	601,050	I	See Footnote
Common Shares^F5,F6	Oct 31, 2017	S	1,050	$30.51	D	600,000	I	See Footnote
Common Shares^F7,F3	Nov 1, 2017	S	18,074	$29.10	D	581,926	I	See Footnote
Common Shares^F8,F3	Nov 1, 2017	S	6,926	$29.62	D	575,000	I	See Footnote
Common Shares^F7,F6	Nov 1, 2017	S	18,074	$29.10	D	581,926	I	See Footnote
Common Shares^F8,F6	Nov 1, 2017	S	6,926	$29.62	D	575,000	I	See Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

F1These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.38 - $29.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
F3These shares are held by The Vladimir Coric Family Trust 2013.
F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.38 - $30.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4.
F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.44 - $30.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (5) to this Form 4.
F6The shares are held by The Vladimir Coric Marital Trust 2013.
F7The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.45 - $29.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (10) to this Form 4.
F8The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.45 - $29.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (11) to this Form 4.